• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用生理动力学模型预测大豆异黄酮染料木黄酮在大鼠肠道微生物中的代谢产物 S-马吲哚及其对 ERα 激活的影响。

Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation.

机构信息

Division of Toxicology, Wageningen University and Research, Wageningen, 6708 WE, The Netherlands.

Faculty of Natural Resources and Agro-Industry, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon, 47000, Thailand.

出版信息

Mol Nutr Food Res. 2020 Mar;64(6):e1900912. doi: 10.1002/mnfr.201900912. Epub 2020 Feb 25.

DOI:10.1002/mnfr.201900912
PMID:32027771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7154660/
Abstract

SCOPE

To predict gut microbial metabolism of xenobiotics and the resulting plasma concentrations of metabolites formed, an in vitro-in silico-based testing strategy is developed using the isoflavone daidzein and its gut microbial metabolite S-equol as model compounds.

METHODS AND RESULTS

Anaerobic rat fecal incubations are optimized and performed to derive the apparent maximum velocities (V ) and Michaelis-Menten constants (K ) for gut microbial conversion of daidzein to dihydrodaidzein, S-equol, and O-desmethylangolensin, which are input as parameters for a physiologically based kinetic (PBK) model. The inclusion of gut microbiota in the PBK model allows prediction of S-equol concentrations and slightly reduced predicted maximal daidzein concentrations from 2.19 to 2.16 µm. The resulting predicted concentrations of daidzein and S-equol are comparable to in vivo concentrations reported.

CONCLUSION

The optimized in vitro approach to quantify kinetics for gut microbial conversions, and the newly developed PBK model for rats that includes gut microbial metabolism, provide a unique tool to predict the in vivo consequences of daidzein microbial metabolism for systemic exposure of the host to daidzein and its metabolite S-equol. The predictions reveal a dominant role for daidzein in ERα-mediated estrogenicity despite the higher estrogenic potency of its microbial metabolite S-equol.

摘要

范围

为了预测外源性物质在肠道微生物中的代谢以及由此形成的代谢物在血浆中的浓度,我们开发了一种基于体外-计算的测试策略,该策略以异黄酮染料木黄酮及其肠道微生物代谢物 S-雌马酚为模型化合物。

方法和结果

优化并进行了厌氧大鼠粪便孵育,以得出肠道微生物将染料木黄酮转化为二氢染料木黄酮、S-雌马酚和 O-去甲安哥拉辛的表观最大速度(V)和米氏常数(K),这些参数被输入到生理相关的动力学(PBK)模型中。在 PBK 模型中包含肠道微生物群,可预测 S-雌马酚的浓度,并略微降低预测的最大染料木黄酮浓度,从 2.19 降至 2.16µm。由此预测的染料木黄酮和 S-雌马酚浓度与体内报道的浓度相当。

结论

优化的体外方法可定量肠道微生物转化的动力学,新开发的包含肠道微生物代谢的大鼠 PBK 模型,为预测染料木黄酮微生物代谢对宿主系统暴露于染料木黄酮及其代谢物 S-雌马酚的体内后果提供了独特的工具。预测结果表明,尽管其微生物代谢物 S-雌马酚的雌激素效力更高,但染料木黄酮在 ERα 介导的雌激素活性中起主导作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/9527812b9176/MNFR-64-1900912-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/0a7e94068f4c/MNFR-64-1900912-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/2c8727bc4c1f/MNFR-64-1900912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/eef339d935e1/MNFR-64-1900912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/c45c128df440/MNFR-64-1900912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/01940f77ad2a/MNFR-64-1900912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/2a4462d6edae/MNFR-64-1900912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/9e27e0505dab/MNFR-64-1900912-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/57673c66aa01/MNFR-64-1900912-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/7d3dffd5e079/MNFR-64-1900912-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/9527812b9176/MNFR-64-1900912-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/0a7e94068f4c/MNFR-64-1900912-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/2c8727bc4c1f/MNFR-64-1900912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/eef339d935e1/MNFR-64-1900912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/c45c128df440/MNFR-64-1900912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/01940f77ad2a/MNFR-64-1900912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/2a4462d6edae/MNFR-64-1900912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/9e27e0505dab/MNFR-64-1900912-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/57673c66aa01/MNFR-64-1900912-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/7d3dffd5e079/MNFR-64-1900912-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/050f/7154660/9527812b9176/MNFR-64-1900912-g009.jpg

相似文献

1
Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation.应用生理动力学模型预测大豆异黄酮染料木黄酮在大鼠肠道微生物中的代谢产物 S-马吲哚及其对 ERα 激活的影响。
Mol Nutr Food Res. 2020 Mar;64(6):e1900912. doi: 10.1002/mnfr.201900912. Epub 2020 Feb 25.
2
Use of Physiologically Based Pharmacokinetic Modeling to Predict Human Gut Microbial Conversion of Daidzein to S-Equol.应用生理药代动力学模型预测大豆黄素在人体肠道微生物转化为 S-马栗树皮素。
J Agric Food Chem. 2022 Jan 12;70(1):343-352. doi: 10.1021/acs.jafc.1c03950. Epub 2021 Dec 2.
3
Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women.通过肠道微生物组最大限度地提高大豆异黄酮的雌激素潜力:对绝经后妇女心血管代谢健康的影响。
Nutrients. 2022 Jan 27;14(3):553. doi: 10.3390/nu14030553.
4
Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats.大豆黄素和染料木黄酮可被共生大鼠肠道中的 Slackia isoflavoniconvertens 转化为雌马酚和 5-羟基雌马酚。
J Nutr. 2012 Jan;142(1):40-6. doi: 10.3945/jn.111.148247. Epub 2011 Nov 23.
5
Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.代谢组学揭示了具有心脏代谢危险因素的成年人中三种大豆苷元代谢表型之间的差异。
Mol Nutr Food Res. 2017 Jan;61(1). doi: 10.1002/mnfr.201600132. Epub 2016 Aug 3.
6
[Microbial conversion of daidzein affects fecal equol concentration and bacterial composition of rats with or without ovariectomy].[大豆苷元的微生物转化对去势和未去势大鼠粪便中雌马酚浓度及细菌组成的影响]
Wei Sheng Wu Xue Bao. 2012 Jul 4;52(7):866-74.
7
Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production.大豆黄酮摄入通过增加产生黄豆苷元的肠道细菌与黄豆苷元产生状态相关。
Nutrients. 2019 Feb 19;11(2):433. doi: 10.3390/nu11020433.
8
Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.超重或肥胖与绝经前后女性肠道微生物群落有关,该群落无法将大豆异黄酮黄豆苷元代谢为O-去甲基安哥拉紫檀素。
Maturitas. 2017 May;99:37-42. doi: 10.1016/j.maturitas.2017.02.006. Epub 2017 Feb 16.
9
Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.大豆苷元:来自大豆异黄酮的细菌代谢产物及其推测的有益健康作用。
Nutrients. 2019 Sep 16;11(9):2231. doi: 10.3390/nu11092231.
10
In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production.人粪便与大豆苷元及抗生素的体外培养表明,负责产生雌马酚的细菌存在个体差异。
J Nutr. 2004 Mar;134(3):596-9. doi: 10.1093/jn/134.3.596.

引用本文的文献

1
Lactulose selectively stimulates members of the gut microbiota, as determined by multi-modal activity-based sorting.通过基于多模式活性的分选确定,乳果糖可选择性刺激肠道微生物群的成员。
Gut Microbes. 2025 Dec;17(1):2525482. doi: 10.1080/19490976.2025.2525482. Epub 2025 Jun 27.
2
Precision Dietary Intervention: Gut Microbiome and Meta-metabolome as Functional Readouts.精准饮食干预:以肠道微生物组和代谢组作为功能读数
Phenomics. 2025 Feb 14;5(1):23-50. doi: 10.1007/s43657-024-00193-7. eCollection 2025 Feb.
3
Flavonoids, gut microbiota, and host lipid metabolism.

本文引用的文献

1
Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.大豆苷元:来自大豆异黄酮的细菌代谢产物及其推测的有益健康作用。
Nutrients. 2019 Sep 16;11(9):2231. doi: 10.3390/nu11092231.
2
Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.应用体外-计算毒理学策略预测吡咯里西啶生物碱 lasiocarpine 和 riddelliine 在肝脏毒性方面的种间和种族间的人体差异。
Arch Toxicol. 2019 Mar;93(3):801-818. doi: 10.1007/s00204-019-02397-7. Epub 2019 Jan 19.
3
Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics.
类黄酮、肠道微生物群与宿主脂质代谢。
Eng Life Sci. 2023 Nov 13;24(5):2300065. doi: 10.1002/elsc.202300065. eCollection 2024 May.
4
In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids.关于剂量、生物活化分数和所使用的终点对吡咯里西啶生物碱氮氧化物相对于母体吡咯里西啶生物碱的相对效价的影响的体外-计算机模拟研究。
Curr Res Toxicol. 2024 Mar 1;6:100160. doi: 10.1016/j.crtox.2024.100160. eCollection 2024.
5
Comparison of three different lactic acid bacteria-fermented proteins on RAW 264.7 osteoclast and MC3T3-E1 osteoblast differentiation.三种不同乳酸菌发酵蛋白对 RAW 264.7 破骨细胞和 MC3T3-E1 成骨细胞分化的比较。
Sci Rep. 2023 Dec 7;13(1):21575. doi: 10.1038/s41598-023-49024-1.
6
Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays.利用基于体外生物活性测定的安全对照化合物值对人类暴露于雌激素的下一代风险进行评估。
Arch Toxicol. 2023 Jun;97(6):1547-1575. doi: 10.1007/s00204-023-03480-w. Epub 2023 Apr 22.
7
Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone.作为一种强效抗癌异黄酮的雌马酚的肠道微生物群辅助合成、细胞相互作用及协同作用观点
Pharmaceuticals (Basel). 2022 Nov 16;15(11):1418. doi: 10.3390/ph15111418.
8
Use of Physiologically Based Pharmacokinetic Modeling to Predict Human Gut Microbial Conversion of Daidzein to S-Equol.应用生理药代动力学模型预测大豆黄素在人体肠道微生物转化为 S-马栗树皮素。
J Agric Food Chem. 2022 Jan 12;70(1):343-352. doi: 10.1021/acs.jafc.1c03950. Epub 2021 Dec 2.
9
Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.基于生理学的动力学模型预测,与 riddelliine 相比, riddelliine N-氧化物在大鼠体内的相对效力与剂量有关。
Arch Toxicol. 2022 Jan;96(1):135-151. doi: 10.1007/s00204-021-03179-w. Epub 2021 Oct 20.
10
PBK Model-Based Prediction of Intestinal Microbial and Host Metabolism of Zearalenone and Consequences for its Estrogenicity.PBK 模型预测玉米赤霉烯酮的肠道微生物和宿主代谢及其雌激素活性的后果。
Mol Nutr Food Res. 2021 Dec;65(23):e2100443. doi: 10.1002/mnfr.202100443. Epub 2021 Oct 25.
抗生素处理大鼠的肠道组织、盲肠内容物和粪便中与微生物群相关的代谢物变化。
Toxicol Appl Pharmacol. 2018 Sep 15;355:198-210. doi: 10.1016/j.taap.2018.06.028. Epub 2018 Jul 6.
4
Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.运用基于生理学的动力学模型辅助反向剂量学方法,将离体细胞毒性数据转化为拉西卡品和瑞德利碱在大鼠体内肝脏毒性的预测值。
Food Chem Toxicol. 2018 Jun;116(Pt B):216-226. doi: 10.1016/j.fct.2018.04.012. Epub 2018 Apr 7.
5
Extensive impact of non-antibiotic drugs on human gut bacteria.非抗生素药物对人体肠道细菌的广泛影响。
Nature. 2018 Mar 29;555(7698):623-628. doi: 10.1038/nature25979. Epub 2018 Mar 19.
6
Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.通过体外雌激素数据的反向剂量测定,建立一种通用的基于生理学的动力学模型,以预测大鼠体内的子宫增重反应。
Arch Toxicol. 2018 Mar;92(3):1075-1088. doi: 10.1007/s00204-017-2140-5. Epub 2017 Dec 12.
7
Microbial Ecology along the Gastrointestinal Tract.胃肠道中的微生物生态学
Microbes Environ. 2017 Dec 27;32(4):300-313. doi: 10.1264/jsme2.ME17017. Epub 2017 Nov 10.
8
Plasma bioavailability and changes in PBMC gene expression after treatment of ovariectomized rats with a commercial soy supplement.用一种商业大豆补充剂治疗去卵巢大鼠后血浆生物利用度及外周血单核细胞基因表达的变化
Toxicol Rep. 2015 Jan 2;2:308-321. doi: 10.1016/j.toxrep.2014.12.013. eCollection 2015.
9
In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.基于体外-计算机模拟分析大豆植物雌激素染料木黄酮在人体内的剂量依赖性体内雌激素活性。
Br J Pharmacol. 2017 Aug;174(16):2739-2757. doi: 10.1111/bph.13900. Epub 2017 Jul 11.
10
Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.一种结合体外生理药代动力学(PBK)和蒙特卡洛模拟方法的开发,用于预测苯酚诱导的发育毒性中的个体间人类差异。
Toxicol Sci. 2017 Jun 1;157(2):365-376. doi: 10.1093/toxsci/kfx054.